Publications

TitleAbstractYear(sorted descending)
Filter
PMID
Filter
a phase-ii trial of corynebacterium parvum as adjuvant to surgery in the treatment of operable lung cancer.a phase-ii randomized trial has been undertaken in 49 patients with operable lung cancer, to determine the effect of a single iv infusion of killed c. parvum vaccine as an adjuvant to surgery. the number of patients was insufficient to provide a decisive result, but analysis 6 years after the last patient was admitted shows that the adjuvant therapy certainly did not shorten, and may well have prolonged, survival. of the patients with squamous cell carcinoma who were alive 1 year after operation ...19836362846
the non-sporing anaerobic bacteria in human faeces. 19744599664
Displaying items 1 - 2 of 2